knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 03:26:06 - browse：44177

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Norman Reedus' Daryl Dixon

leisure time

hotspot

WSS

Why some people catch Covid but never get sick

Ohio still needs to do more to protect the right to abortion

Carbon Health diabetes program, a test of data

Type 2 diabetes prevention programs work at large scale: study

New warning issued for rebooking air travel after delays, cancellations

Type 2 diabetes prevention programs work at large scale: study

Wikipedia

knowledge

entertainment

Drug repurposing or repositioning? The language matters

UnitedHealth sued over use of algorithm in Medicare Advantage plans

The high cost of giving birth even with insurance

After decades in use, heart stents finally beat placebo

Peter Hotez and the public health issue of online harassment

Why some people catch Covid but never get sick

As demand for Covid shots wanes, Moderna seeks its next success

How dance can help health care workers heal from trauma

BioMarin wins approval for gene therapy to treat hemophilia A

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

leisure time

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

'Reaching a detente': STAT's Helen Branswell on covering Covid

NIH chief: government has fallen behind pharma on clinical trials

Couple fighting to bring baby home from Mexico are finally reunited

Publishing genetic code of viruses could cause disaster

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

focus

leisure time

hotspot

focus